<img alt="" height="1" width="1" />FDA approves Salix's application to market Xifaxan for liver diseaseNews & ObserverSalix also plans to seek approval to tout Xifaxan as a treatment for irritable bowel syndrome. The company plans to seek FDA approval in the next few months ...<nobr>and more »</nobr> |